Axa
AZN icon

Axa’s AstraZeneca AZN Stock Holding History

Axa’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-235,592
Closed -$32.9M – 168
2025
Q2 		$32.9M Buy
235,592
+3,497
+2% +$490K 0.09% 190
2025
Q1 		$34.1M Sell
232,095
-2,727
-1% -$395K 0.11% 185
2024
Q4 		$30.8M Buy
234,822
+23,226
+11% +$3.25M 0.09% 205
2024
Q3 		$33M Buy
211,596
+11,475
+6% +$1.85M 0.1% 204
2024
Q2 		$31.2M Buy
200,121
+182,560
+1,040% +$27.5M 0.09% 194
2024
Q1 		$2.38M Buy
17,561
+2,622
+18% +$347K 0.01% 726
2023
Q4 		$2.01M Buy
14,939
+2,528
+20% +$329K 0.01% 733
2023
Q3 		$1.68M Buy
12,411
+2,582
+26% +$353K 0.01% 742
2023
Q2 		$1.41M Sell
9,829
-4
-0% -$589 ﹤0.01% 783
2023
Q1 		$1.36M Hold
9,833
– – ﹤0.01% 821
2022
Q4 		$1.33M Buy
+9,833
New +$1.23M ﹤0.01% 837
2022
Q1 		– Sell
-304
Closed -$35K – 1183
2021
Q4 		$35K Hold
304
– – ﹤0.01% 1150
2021
Q3 		$36K Buy
+304
New +$35.4K ﹤0.01% 1217
2021
Q1 		– Sell
-975
Closed -$97K – 1209
2020
Q4 		$97K Buy
975
+35
+4% +$3.71K ﹤0.01% 1202
2020
Q3 		$103K Buy
+940
New +$105K ﹤0.01% 1194

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Axa's AZN Position: Q3 2025 in Review

Axa sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 235,592 shares — an estimated $32.9M sold.

Axa first reported a position in AZN in Q3 2020 and held it in 15 quarters. The position peaked at $34.1M in Q1 2025. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Axa reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Axa sold 235,592 AstraZeneca shares in Q3 2025, an estimated $32.9M.
  • Axa first reported a position in AstraZeneca in Q3 2020 and held it in 15 quarters.
  • Axa's AstraZeneca position peaked at $34.1M in Q1 2025.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.